FDA Recommendations Regarding Gowns and Surgical Masks
On March 11, 2020, the Food and Drug Administration (FDA) issued a letter to health care providers intended to aid in the management of gowns and surgical masks. The letter outlines recommended conservation strategies for use by health care organizations and personnel. For surgical masks and gowns, the FDA recommends that health care providers follow these strategies based on the supply needs of their health care organization. Gowns that are ANSI/AAMI PB70 Level 1 and 2 barrier protection are considered non-surgical isolation gowns. Gowns that have ANSI/AAMI PB70 Level 3 and 4 barrier protection and/or can be used for a sterile procedure are considered surgical gowns or surgical isolation gowns.
Conventional Capacity Strategies
supply levels are adequate to provide patient care without any change in routine practice
• Use FDA-cleared surgical masks and gowns according to labeling and local, state, and federal requirements.
• Employ engineering and administrative controls following Centers for Disease Control and Prevention (CDC) and Healthcare Infection Control Practices Advisory Committee (HICPAC) guidelines to reduce the need for surgical masks while minimizing risks to health care providers and patients.
• Specifically, for gowns, consider:
o Implementing the use of reusable gowns instead of disposable single use gowns. o Using ANSI/AAMI PB70 standard Level 3 or 4 gown for surgery/invasive procedures with a medium to high risk of contamination. o Using ANSI/AAMI PB70 standard Level 1 or 2 gown for surgery/invasive procedures with a low risk of contamination. o Using non-surgical isolation gowns for routine care of patients that are suspected to be infected with COVID-19.
Contingency Capacity Strategies
limited supply levels may change patient care, but may not have a significant impact on patient care and health care provider safety
• During times of limited access to surgical masks, facilities could consider having health care providers continue to wear the same surgical mask, remove only used gloves and gowns , and perform hand hygiene between treating patients with the same infectious disease diagnosis or exposure who are maintained in a confined area. If the mask, gloves, or gowns become contaminated, replace them.
• For training, use gowns that are beyond the manufacturer-designated shelf life, if available.
• Prioritize the use of gowns and surgical masks by the type of activities required for patients. If there are shortages of gowns, they should be prioritized for aerosol-generating procedures, care activities where splashes and sprays are anticipated, and high-contact patient care activities that provide opportunities for transfer of pathogens to the hands and clothing of health care providers. The FDA notes that it is collaborating with manufacturers of surgical masks and gowns to better understand the current supply chain issues related to the COVID-19 outbreak, and to avoid any widespread shortages of these products. According to an FAQ issued by the FDA on shortages of surgical masks and gowns, the agency is also collaborating with manufacturers of PPE to help facilitate mitigation strategies related to the COVID-19 outbreak. Medical device manufacturers are not required to notify the FDA when they become aware of a circumstance that could lead to a device shortage or meaningful disruption in the supply of that device in the United States.
Crisis or Alternate Strategies
For potential or actual supply issues, email information to the FDA at deviceshortages@fda.hhs.gov. Anyoneuser, patient, manufacturer, or organization within the supply chain -who is aware of a delay in distribution of a product, and/or anticipates a potential or actual shortage, can notify the agency.
FDA Recommendations Regarding Gloves
On March 20, 2020, the Food and Drug Administration (FDA) issued a letter to health care providers intended to aid in the management of surgeons' gloves and patient examination gloves. The following conservation strategies for use by health care organizations and personnel are categorized for a range of needs and supply levels and are intended to assist health care organizations as they determine procedures during the COVID-19 pandemic. The FDA issued frequently asked questions (FAQ) on shortages of medical gloves.
The conservation strategies described below are intended to augment, and not intended to replace, specific controls and procedures developed by health care organizations, the Centers for Disease Control and Prevention (CDC), or the CDC's Healthcare Infection Control Practices Advisory Committee (HICPAC) to aid in infection prevention and control. These strategies are not limited to use in the care of patients infected with COVID-19. Health care organizations may find additional useful information in guidelines on modifications to medical standards of care during a crisis.
Conservation Strategies
For medical gloves, health care providers may wish to consider these strategies and risk mitigations based on the supply needs of their health care organization. Conventional Capacity Strategies (supply levels are adequate to provide patient care without any change in routine practice)
• Nonsterile disposable patient examination gloves, which are used for routine patient care in health care settings, are appropriate for the care of patients with suspected or confirmed COVID-19.
• Use FDA-cleared medical gloves according to labeling and local, state, and federal requirements.
• Employ engineering and administrative controls following the CDC's and HICPAC guidelines to reduce the need for medical gloves while minimizing risks to health care providers and patients. Some of the CDC's Strategies for Optimizing the Supply of N95 Respirators may also be useful for gloves conservation.
• Reserve use of sterile gloves for procedures in which sterility is required.
Contingency Capacity Strategies
• For training or demonstration in which broad barrier protection is not needed, use gloves that are beyond the manufacturer-designated shelf life, if available.
Crisis or Alternate Strategies if Medical Gloves are Running Low or Not Available
may need to be considered if medical glove supplies are critically low and demand is high
• Refer to the CDC's Hand Hygiene in Healthcare Settings
• Use medical gloves beyond the manufacturer-designated shelf life in a setting where there is a lower risk of transmission (for example, non-surgical, non-sterile). The user should visibly inspect the gloves prior to use and, if there are concerns (for example, discolored or visible tears, holes), discard the gloves.
• Extend the use of medical gloves for health care providers without changing the gloves between patients with the same infectious disease diagnosis or exposure and no other infections. Gloved hands can be cleaned between patients and at other times when hand hygiene would normally be performed during routine patient care. Alcohol-based hand sanitizers may degrade vinyl gloves. If a glove becomes damaged (for example, discolored, deteriorated, visible tears, holes) or contaminated (for example, body fluids, chemotherapy drugs), replace it.
• Consider using radiographic protective gloves or radiation attenuating surgeon's gloves that are clean and offer fluid barrier protection. These gloves cannot be sterilized but can be cleaned following the manufacturer's labeling.
• Consider using non-medical gloves such as those used for food service, embalming, cleaning, or other industrial-grade gloves that most closely align with the ASTM standards for medical gloves as outlined in the FDA's Medical Glove Guidance Manual.
• Be aware that counterfeit medical and non-medical gloves may be on the market, especially during this time of reduced supply.
CDC COVID-19 Interim Infection Prevention and Control Recommendations
The CDC has issued guidance for health care personnel caring for patients with confirmed or possible COVID-19 infection. Based on the current COVID-19 situation and availability of PPE, CDC has issued specific recommendations. CDC instructs health care personnel to adhere to Standard, Contact, and Airborne Precautions when caring for patients with COVID-19 infection. These precautions include the use of PPE.
PPE Availability
CDC communicates regularly with health care industry partners, as well as PPE manufacturers and distributors, to assess availability of PPE. Given decreases in exports from select countries and increases in demand due to the global outbreak, manufacturers of select types of PPE are reporting increased volume of orders and challenges in meeting order demands. Specific challenges are being reported for N95 respirators and facemasks. Orders received are up to 10-fold normal demand for these items. The CDC states that plans for surge manufacturing globally are underway.
Distributors of select types of PPE are also reporting an increased volume of orders from customers and challenges in meeting order demands for PPE, specifically for N95 respirators and facemasks. Due to decreased exports from overseas by manufacturers, distributors are reporting that these items are being placed on allocation, and orders are being filled based on historical demands for existing customers. At present, shortfalls may be anticipated to continue for the next 3-4 months.
The CDC has stated that U.S. health care systems are reporting higher than normal use for N95 respirators, due to fit testing and stockpiling, to prepare for possible widespread COVID-19 transmission. Orders are being placed in higher volumes to meet these needs. Some health care systems have begun reporting that orders for N95 respirators and facemasks are not being filled or are only being partially filled by distributors. In addition, major pharmacy chains have reported stock outs of N95 respirators and facemasks with delays in replenishment of inventory.
CDC is encouraging health care systems to implement the following strategies to conserve supplies.
Strategies for Optimizing the Supply of Eye Protection Conventional Capacity Strategies
• Use eye protection according to product labeling and local, state, and federal requirements.
Contingency Capacity Strategies
• Selectively cancel elective and non-urgent procedures and appointments for which eye protection is typically used by health care personnel (HCP).
• Shift eye protection supplies from disposable to re-usable devices.
o Consider preferential use of powered air purifying respirators (PAPRs) or full-face elastomeric respirators which have built-in eye protection. o Ensure appropriate cleaning and disinfection between users if goggles or reusable face shields are used.
• Implement extended use of eye protection.
o Eye protection should be removed and reprocessed if it becomes visibly soiled or difficult to see through. o Eye protection should be discarded if damaged. o HCP should take care not to touch their eye protection. If they touch or adjust their eye protection they must immediately perform hand hygiene. o HCP should leave patient care area if they need to remove their eye protection. See protocol for removing and reprocessing eye protection below.
Crisis Capacity Strategies
• Cancel all elective and non-urgent procedures and appointments for which eye protection is typically used by HCP.
• Use eye protection devices beyond the manufacturer-designated shelf life during patient care activities.
• Prioritize eye protection for selected activities such as:
o During care activities where splashes and sprays are anticipated, which typically includes aerosol generating procedures. o During activities where prolonged face-to-face or close contact with a potentially infectious patient is unavoidable.
• Consider using safety glasses that have extensions to cover the side of the eyes.
• 
Selected Options for Reprocessing Eye Protection
• Adhere to recommended manufacturer instructions for cleaning and disinfection.
• When manufacturer instructions for cleaning and disinfection are unavailable, such as for single use disposable face shields, consider: o While wearing gloves, carefully wipe the inside, followed by the outside of the face shield or goggles using a clean cloth saturated with neutral detergent solution or cleaner wipe. o Carefully wipe the outside of the face shield or goggles using a wipe or clean cloth saturated with Environmental Protection Agency (EPA)-registered hospital disinfectant solution. o Wipe the outside of face shield or goggles with clean water or alcohol to remove residue. o Fully dry (air dry or use clean absorbent towels). o Remove gloves and perform hand hygiene.
Strategies for Optimizing the Supply of Isolation Gowns Conventional Capacity Strategies
• Use isolation gown alternatives that offer equivalent or higher protection.
Contingency Capacity Strategies
• Selectively cancel elective and non-urgent procedures and appointments for which a gown is typically used by HCP.
• Shift gown use towards cloth isolation gowns.
o Laundry operations and personnel may need to be augmented to facilitate additional washing loads and cycles. o Systems are established to routinely inspect, maintain, and replace reusable gowns when needed.
• Consider the use of coveralls.
• Use of expired gowns beyond the manufacturer-designated shelf life for training.
• Use gowns or coveralls conforming to international standards.
Crisis Capacity Strategies
• Cancel all elective and non-urgent procedures and appointments for which a gown is typically used by HCP.
• Extended use of isolation gowns.
• Re-use of cloth isolation gowns.
• Prioritize gowns. Gowns should be prioritized for the following activities:
o During care activities where splashes and sprays are anticipated, which typically includes aerosol generating procedures 
Strategies for Optimizing the Supply of Face Masks Conventional Capacity Strategies
Use facemasks according to product labeling and local, state, and federal requirements.
• FDA-cleared surgical masks are designed to protect against splashes and sprays and are prioritized for use when such exposures are anticipated, including surgical procedures.
• Facemasks that are not regulated by FDA, such as some procedure masks, which are typically used for isolation purposes, may not provide protection against splashes and sprays.
Contingency Capacity Strategies
• Selectively cancel elective and non-urgent procedures and appointments for which a facemask is typically used by HCP.
• Remove facemasks for visitors in public areas.
• Implement extended use of facemasks.
o The facemask should be removed and discarded if soiled, damaged, or hard to breathe through. o HCP must take care not to touch their facemask. If they touch or adjust their facemask they must immediately perform hand hygiene. o HCP should leave the patient care area if they need to remove the facemask.
• Restrict facemasks to use by HCP, rather than patients for source control.
Crisis Capacity Strategies
• Cancel all elective and non-urgent procedures and appointments for which a facemask is typically used by HCP.
• Use facemasks beyond the manufacturer-designated shelf life during patient care activities.
• Implement limited re-use of facemasks.
o The facemask should be removed and discarded if soiled, damaged, or hard to breathe through. o Not all facemasks can be re-used. o HCP should leave patient care area if they need to remove the facemask. Facemasks should be carefully folded so that the outer surface is held inward and against itself to reduce contact with the outer surface during storage. The folded mask can be stored between uses in a clean sealable paper bag or breathable container. • Use a face shield that covers the entire front (that extends to the chin or below) and sides of the face with no facemask.
• Consider use of expedient patient isolation rooms for risk reduction.
• Consider use of ventilated headboards.
• HCP use of homemade masks.
Strategies for Optimizing the Supply of N95 Respirators Conventional Capacity Strategies
• Engineering controls reduce exposures for HCP by placing a barrier between the hazard and the HCP.
Engineering controls can be very effective as part of a suite of strategies to protect HCP without placing primary responsibility of implementation on them. In addition to the CDC's Interim Infection Prevention and Control Recommendations for COVID-10, the agency has issued and FAQ on Infection Control and an FAQ About PPE.
